Page last updated: 2024-08-21

hydrazine and T-Cell Lymphoma

hydrazine has been researched along with T-Cell Lymphoma in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (66.67)	2.80

Authors

Authors	Studies
Chen, J; Du, Y; Huang, K; Li, Y; Liu, H; Ma, L; Nie, D; Wang, J; Xiao, J; Xiao, X; Xie, S; Yang, W	1
Chan, JY; Farid, M; Lim, C; Lim, ST; Martin, P; Poon, E; Somasundaram, N; Tang, T; Tao, M; Toh, SQ; Yan, SX; Yunon, MJ	1
Shrivastav, A; Singh, NK; Singh, SM	1

Trials

1 trial(s) available for hydrazine and T-Cell Lymphoma

Article	Year
Phase I study of selinexor in combination with dexamethasone, ifosfamide, carboplatin, etoposide chemotherapy in patients with relapsed or refractory peripheral T-cell or natural-killer/T-cell lymphoma Haematologica, 2021, 12-01, Volume: 106, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dexamethasone; Etoposide; Humans; Hydrazines; Ifosfamide; Lymphoma, T-Cell; Neoplasm Recurrence, Local; Triazoles	2021

Article

Year

Phase I study of selinexor in combination with dexamethasone, ifosfamide, carboplatin, etoposide chemotherapy in patients with relapsed or refractory peripheral T-cell or natural-killer/T-cell lymphoma

Haematologica, 2021, 12-01, Volume: 106, Issue:12

Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dexamethasone; Etoposide; Humans; Hydrazines; Ifosfamide; Lymphoma, T-Cell; Neoplasm Recurrence, Local; Triazoles

2021

Other Studies

2 other study(ies) available for hydrazine and T-Cell Lymphoma

Article	Year
Prognostic and therapeutic significance of XPO1 in T-cell lymphoma. Experimental cell research, 2022, 07-15, Volume: 416, Issue:2 Topics: Active Transport, Cell Nucleus; Apoptosis; Cell Line, Tumor; Exportin 1 Protein; Humans; Hydrazines; Karyopherins; Lymphoma, T-Cell; Prognosis; Receptors, Cytoplasmic and Nuclear	2022
Synthesis, characterization and antitumor studies of Mn(II), Ni(II), Cu(II) and Zn(II) complexes of N-nicotinoyl-n'-o-hydroxythiobenzhydrazide. Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2003, Volume: 16, Issue:2 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Division; Cell Line, Tumor; Copper; Drug Screening Assays, Antitumor; Female; Hydrazines; Lymphoma, T-Cell; Male; Manganese; Mice; Mice, Inbred BALB C; Nickel; Organometallic Compounds; Survival Rate; Tumor Cells, Cultured; Zinc	2003

Article

Year

Prognostic and therapeutic significance of XPO1 in T-cell lymphoma.

Experimental cell research, 2022, 07-15, Volume: 416, Issue:2

Topics: Active Transport, Cell Nucleus; Apoptosis; Cell Line, Tumor; Exportin 1 Protein; Humans; Hydrazines; Karyopherins; Lymphoma, T-Cell; Prognosis; Receptors, Cytoplasmic and Nuclear

2022

Synthesis, characterization and antitumor studies of Mn(II), Ni(II), Cu(II) and Zn(II) complexes of N-nicotinoyl-n'-o-hydroxythiobenzhydrazide.

Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2003, Volume: 16, Issue:2

Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Division; Cell Line, Tumor; Copper; Drug Screening Assays, Antitumor; Female; Hydrazines; Lymphoma, T-Cell; Male; Manganese; Mice; Mice, Inbred BALB C; Nickel; Organometallic Compounds; Survival Rate; Tumor Cells, Cultured; Zinc

2003